Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0008Subject Initials :R-HDOB :02/06/1993Sex:FemaleRace:AsianHeight:158cmWeight:51.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/11/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/27/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
laparoscope hydrotubationUk-Unk-2013Not on treatment/medication



20-APR-16
NA/EMR700623-541/C02-0008
Page 1 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0010Subject Initials :Y-HDOB :10/18/1985Sex:FemaleRace:AsianHeight:153cmWeight:47.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/11/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/29/201506/02/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



20-APR-16
NA/EMR700623-541/C02-0010
Page 2 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0011Subject Initials :P-XDOB :12/07/1994Sex:FemaleRace:AsianHeight:160cmWeight:60.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/11/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/27/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
ectopic pregnancy Salping ectomyUk-Unk-2013On treatment/medication



20-APR-16
NA/EMR700623-541/C02-0011
Page 3 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0023Subject Initials :JYFDOB :11/10/1981Sex:FemaleRace:AsianHeight:163cmWeight:70.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/12/2015300
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Hysteroscopy Salpingemphraxis Uk-Mar-2015Not on treatment/medication



20-APR-16
NA/EMR700623-541/C02-0023
Page 4 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0024Subject Initials :HXGDOB :10/06/1992Sex:FemaleRace:AsianHeight:150cmWeight:55.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/12/2015200
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing
 



20-APR-16
NA/EMR700623-541/C02-0024
Page 5 of 22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0026Subject Initials :HCJDOB :07/07/1993Sex:FemaleRace:AsianHeight:161cmWeight:53.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/12/2015200
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparotomy with left tubal ectopic pregnancy resectionUk-Unk-2011Not on treatment/medication
Under ectopic pregnancy laparoscopic conservative surgeryUk-Unk-2012Not on treatment/medication



20-APR-16
NA/EMR700623-541/C02-0026
Page 6 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0028Subject Initials :XHLDOB :04/12/1981Sex:FemaleRace:AsianHeight:158cmWeight:65.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/12/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS risk05/25/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Left abdominal ectopic pregnancy salpingectomyUk-Unk-2002Not on treatment/medication
Right next laparoscopic tubal ectopic pregnancy surgeryUk-Unk-2010Not on treatment/medication
Conservative treatment of ectopic pregnancyUk-Unk-2004Not on treatment/medication
Conservative treatment of ectopic pregnancyUk-Unk-2005Not on treatment/medication
 



20-APR-16
NA/EMR700623-541/C02-0028
Page 7 of 22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0029Subject Initials :XLXDOB :06/08/1981Sex:FemaleRace:AsianHeight:158cmWeight:70.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/12/2015250
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/01/201506/07/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Pelvic mass laparoscopic pelvic surgery sticky points, bilateral tubal ostomy, left ovarian drilling, tubal.Uk-Unk-2013Not on treatment/medication



20-APR-16
NA/EMR700623-541/C02-0029
Page 8 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0046Subject Initials :Q-HDOB :10/07/1985Sex:FemaleRace:AsianHeight:161cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/13/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/28/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



20-APR-16
NA/EMR700623-541/C02-0046
Page 9 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0049Subject Initials :HPTDOB :09/16/1980Sex:FemaleRace:AsianHeight:155cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015187.5
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/31/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic surgery appendicitisUk-Unk-2012Not on treatment/medication



20-APR-16
NA/EMR700623-541/C02-0049
Page 10 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0051Subject Initials :yqxDOB :01/15/1983Sex:FemaleRace:AsianHeight:154cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS risk05/31/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
salpingemphraxis,laparoscopic operationUk-Unk-2012Not on treatment/medication
 



20-APR-16
NA/EMR700623-541/C02-0051
Page 11 of 22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0052Subject Initials :YLLDOB :02/07/1992Sex:FemaleRace:AsianHeight:165cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



20-APR-16
NA/EMR700623-541/C02-0052
Page 12 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0053Subject Initials :YNDDOB :04/13/1992Sex:FemaleRace:AsianHeight:155cmWeight:45.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic tubal colostomy, pelvic surgery sticky points.Uk-Unk-2013Not on treatment/medication



20-APR-16
NA/EMR700623-541/C02-0053
Page 13 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0059Subject Initials :J-LDOB :12/23/1984Sex:FemaleRace:AsianHeight:155cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/31/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



20-APR-16
NA/EMR700623-541/C02-0059
Page 14 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0060Subject Initials :Y-WDOB :11/10/1981Sex:FemaleRace:AsianHeight:150cmWeight:45.5kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/27/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic pelvic sticking points, ovarian drilling, tubal surgery to clear.Uk-Unk-2014Not on treatment/medication
 



20-APR-16
NA/EMR700623-541/C02-0060
Page 15 of 22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0061Subject Initials :T-DDOB :02/15/1988Sex:FemaleRace:AsianHeight:161cmWeight:60.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/28/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
salpingemphraxis,laparoscopic operationUk-Unk-2014Not on treatment/medication
 



20-APR-16
NA/EMR700623-541/C02-0061
Page 16 of 22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0062Subject Initials :FQRDOB :07/25/1983Sex:FemaleRace:AsianHeight:162cmWeight:46.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/14/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/30/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Hysteroscopic tubal inspectionUk-May-2014Not on treatment/medication



20-APR-16
NA/EMR700623-541/C02-0062
Page 17 of22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0063Subject Initials :HMCDOB :07/25/1981Sex:FemaleRace:AsianHeight:162cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/15/2015250
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/29/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Hysteroscopic surgery through liquidUk-Unk-2014Not on treatment/medication
 



20-APR-16
NA/EMR700623-541/C02-0063
Page 18 of 22
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-20 End Date:2016-04-21
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0070Subject Initials :ZQCDOB :02/08/1977Sex:FemaleRace:AsianHeight:164cmWeight:67.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/15/2015200
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/28/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing
 



20-APR-16
NA/EMR700623-541/C02-0070
Page 19 of 22